Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Nursing home sued after horrific wound found on dementia patient
After a bout of COVID-19, an 81-year-old woman developed bed sores that became infested with maggots. A lawsuit claims the facility failed to take proper action to treat the injury.
‘A new alternative’: Tiny pacemakers for infants show early promise
A team of pediatric specialists worked closely with representative from Medtronic to develop the new pacemakers. Overall, the tiny devices—approximately one-quarter the size of a traditional pacemaker—were found to be both safe and effective. They are still under development.
Cardiologists make history, complete world’s first robotic transcatheter mitral valve replacements
One of the cardiologists involved in the procedures said they represent "a significant leap forward in structural heart intervention."
FDA approves design updates for Perceval Plus surgical aortic valve
The valve's sutureless, collapsible frame was built to simplify implantation and help patients recover faster following surgery. This updated version features laser-cut details and was shaped using a zero-pressure fixation process.
Cardiologists are first in world to use new TAVR catheter from Boston Scientific
The new Self-Centering Guide Catheter was designed to help care teams with the retrograde crossing of the aortic valve during TAVR. Researchers evaluated the safety and effectiveness of the catheter, sharing their experience in JACC: Cardiovascular Interventions.

COVID-19 precautions implemented in 2020 reduced D2B times in STEMI patients, and its impact continues to reduce times following the pandemic.

Hospitals still struggling to reach pre-COVID heart attack care thresholds due to pandemic disruption

NCDR report finds hospitals are seeing improvements but are still struggling to reach pre-COVID treatment thresholds years after pandemic precautions upended longstanding processes.

Artificial intelligence (AI) is being developed to help make cardiovascular clinical trials more efficient, lead to faster advances in patient care, and bring possible new treatments to heart patients more quickly. The major cardiac research center of Icahn School of Medicine at Mount Sinai announced today that it signed a memorandum of understanding with the Chiba Institute of Technology (CIT) to collaborate on using AI to enhance cardiovascular disease research.

Mount Sinai partners with the Chiba Institute of Technology on AI to transform cardiovascular research

Agreement aims to use AI to help make cardiology clinical trials more efficient and lead to faster advances in patient care.

Patients who quit smoking after PCI see key improvements in their cardiovascular health

This encouraged the study’s authors, who had feared any history of smoking on a regular basis would do permanent, irreversible damage to a patient's cardiovascular health.

Complex PCI among older patients linked to increased risk of death

“Given the dramatic difference in death risk for older adults receiving complex PCI, we suggest that such interventions in this exceptionally vulnerable population should be approached with additional caution," researchers wrote.

Cardiologist compensation much higher at hospitals and health systems than private practices—and the gap is widening

A new 57-page report from MedAxiom explored the latest data on compensation, production, staffing and medical imaging offerings among cardiology programs in the United States.

AI artificial intelligence stethoscope doctor

FDA clears AI model for detecting signs of heart failure in ECGs

The advanced AI model, developed by Anumana with help from Mayo Clinic, could provide value as a screening tool for heart failure.

Cordis finalizes deal to acquire MedAlliance for up to $1.1B

The total value of the acquisition, first announced in 2022, is dependent on various regulatory and commercial milestones.

cannabis use disorder marijuana joint weed smoking

Excessive cannabis use linked to greater risk of heart attack, other cardiovascular events

Researchers examined data from nearly 60,000 adults, focusing on individuals who have been diagnosed with Cannabis Use Disorder.

Clinical

Nursing home sued after horrific wound found on dementia patient

‘A new alternative’: Tiny pacemakers for infants show early promise

Cardiologists make history, complete world’s first robotic transcatheter mitral valve replacements

FDA approves design updates for Perceval Plus surgical aortic valve

Cardiologists are first in world to use new TAVR catheter from Boston Scientific